Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Review overemphasises benefits and downplays serious harms.

Musini V, Mintzes B, Tejani A, Wright JM.

BMJ. 2012 Sep 10;345:e5989; author reply e5990. doi: 10.1136/bmj.e5989. No abstract available.

PMID:
22963943
2.

[Bone quality].

Ito M.

Nihon Rinsho. 2009 May;67(5):921-5. Review. Japanese.

PMID:
19432110
3.

[New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].

Yamaguchi T, Sugimoto T.

Clin Calcium. 2009 Jan;19(1):38-43. doi: CliCa09013843. Review. Japanese.

PMID:
19122263
4.

[Pharmaceutical treatment for patients with hip fracture].

Hagino H.

Clin Calcium. 2010 Sep;20(9):1394-400. doi: CliCa100913941400. Review. Japanese.

PMID:
20808048
5.

[Alendronate].

Okazaki R.

Clin Calcium. 2008 Oct;18(10):1410-6. doi: CliCa081014101416. Review. Japanese.

PMID:
18830037
6.

[Osteoporosis in the elderly--diagnosis and treatment].

Gärtner R.

MMW Fortschr Med. 2005 Feb 17;147(7):33, 35-6. Review. German.

PMID:
18441582
7.

[Role of pharmaceutical intervention in the treatment of osteoporosis and prevention of fracture].

Nakamura T.

Nihon Rinsho. 2009 May;67(5):903-8. Review. Japanese.

PMID:
19432107
8.

[Drug selection guide for osteoporosis determined by the clinical staging, pathophysiology and age].

Tanaka I, Oshima H.

Nihon Rinsho. 2009 May;67(5):915-20. Review. Japanese.

PMID:
19432109
9.

[Evidence of alendronate treatment for osteoporosis].

Harada A.

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:337-43. Review. Japanese. No abstract available.

PMID:
18161127
10.

[Influence on atherosclerosis of improvement of bone mineral density after medication for osteoporosis].

Yamada S, Inaba M, Nishizawa Y.

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:348-51. Review. Japanese. No abstract available.

PMID:
18161129
11.

Hip fractures after stroke and their prevention.

Myint PK, Poole KE, Warburton EA.

QJM. 2007 Sep;100(9):539-45. Epub 2007 Aug 9. Review.

PMID:
17693418
12.

Alendronate for the treatment of osteoporosis in men.

Olszynski WP, Davison KS.

Expert Opin Pharmacother. 2008 Feb;9(3):491-8. doi: 10.1517/14656566.9.3.491 . Review.

PMID:
18220499
13.

Prevention and treatment of senile osteoporosis and hip fractures.

Duque G, Demontiero O, Troen BR.

Minerva Med. 2009 Feb;100(1):79-94. Review.

PMID:
19277006
14.

What is the optimal duration of bisphosphonate therapy?

Ott SM.

Cleve Clin J Med. 2011 Sep;78(9):619-30. doi: 10.3949/ccjm.78a.11022. Review.

15.

[Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].

Soen S.

Clin Calcium. 2012 Mar;22(3):315-20. doi: CliCa1203315320. Review. Japanese.

PMID:
22370297
16.

Management of osteoporosis in geriatric populations.

Schneider DL.

Curr Osteoporos Rep. 2008 Sep;6(3):100-7. Review.

PMID:
18752771
17.

[Recent topics in the treatment of osteoporosis in Japan].

Miki T.

Nihon Ronen Igakkai Zasshi. 2007 Mar;44(2):165-7. Review. Japanese. No abstract available.

18.

[Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].

Nakayama H.

Nihon Rinsho. 2007 Nov 28;65 Suppl 9:499-503. Review. Japanese. No abstract available.

PMID:
18161156
19.

[Drug therapy of secondary osteoporosis: glucocorticoid-induced osteoporosis].

Soen S.

Nihon Rinsho. 2009 May;67(5):985-90. Review. Japanese.

PMID:
19432121
20.

Osteoporosis prevention, detection, and treatment. A mandate for primary care physicians.

Lambing CL.

Postgrad Med. 2000 Jun;107(7):37-41, 44, 47-8 passim. Review.

PMID:
10887444

Supplemental Content

Support Center